The key benchmarks for this are how many people express confidence in the efficacy of our products, and how many would be more likely to do so if there was better regulation.
In that context, the findings from our YouGov survey* are truly illuminating: they are a vindication of why we set up the ACI, launched the ACI charter and committed our members to working towards full novel foods authorisation and standardisation of analytical testing methodologies.
* Methodology: This survey has been conducted using an online interview administered to members of the YouGov Plc UK panel of 800,000+ individuals who have agreed to take part in surveys. Read More
7 Jul, 2020
The ACI will host a series of panels at the upcoming VOXPO virtual event which runs from July 31 to August 2. The ACI are educational partners for the event and our panels will discuss issues relevant to CBD companies and consumers.
19 Jun, 2020
The ACI today announces it will spearhead a CBD Safety Study Consortium to generate data to assess the safety of CBD. This move is in response to calls from regulators around the world who are highlighting the lack of evidence relating to the safety of CBD.
17 Jun, 2020
The ACI today welcomes five new hires to bolster our Regulatory and Compliance Unit. The unit, headed up by Dr Parveen Bhatarah, provides regulatory and compliance support to members of The ACI.
3 Aug, 2020
The European Commission is reviewing whether CBD should be classified as a narcotic. Dr Parveen Bhatarah, Head of Regulatory and Compliance Unit at The Association of the Cannabinoid Industry, explains the impact this could have on both the European and UK markets.
27 Jul, 2020
The CBD industry has just been dealt a potentially dangerous blow, however, with the news that the European Commission is considering classifying it as a narcotic instead of a Novel Food. While a decision won’t be made before September, it could mean that hundreds of CBD and hemp products would be unable to legally retail on the European market.
20 Jul, 2020
Confirmation that the European Union is looking to treat CBD as a narcotic drug have rocked the industry.
BusinessCann reported earlier this month that moves were underway to change the status of cannabidiol (CBD) in the European Union from a food to a drug.
To find out more about membership, fill in the form below and our team will get back to you soon.